JI
Sen. James Inhofe (R-OK) bought $15K-$50K of BMY stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Mar 2, 2017.
The trade happened on Feb 1, 2017, 29 days before it was made public.
BMY has moved +26.4% since the trade date, from $49.29 to $62.32 (Nov 12, 2026 close).
- Traded
- Feb 1, 2017
- Disclosed
- Mar 2, 2017
- Filing delay
- 29 days
- Price since
- +26.4%
- Source
- STOCK Act disclosure